Azelastine nasal spray inhibiting parasympathetic function of tracheal smooth muscle

Hsing Won Wang, Ying Liang Chou, Yueng Hsiang Chu

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Azelastine hydrochloride is a histamine receptor-1 H 1 antagonist with antiinflammatory properties that is available in the United States as Astelin Nasal Spray for rhinitis patients who are suffering from sneezing and rhinorrhea. The effect of H1 antagonists on nasal mucosa in vivo is well known; however, the effect of the drug on tracheal smooth muscle has rarely been explored. During administration via oral intake or inhalation of the H1 antagonist for nasal symptoms, it might affect the trachea. Methods: We examined the effectiveness of azelastine on isolated rat tracheal smooth muscle by testing: 1) the effect on tracheal smooth muscle resting tension; 2) the effect on contraction caused by 106 M methacholine as a parasympathetic mimetic; and 3) the effect on electrically induced tracheal smooth muscle contractions. Results: The results indicated that addition of methacholine to the incubation medium caused the trachea to contract in a dose-dependent manner. Addition of azelastine at doses of 10 5 M or above elicited a significant relaxation response to 10 6 M methacholine-induced contraction. Azelastine could inhibit electrical field stimulation-induced spike contraction. It alone had a minimal effect on the basal tension of trachea as the concentration increased. Conclusions: This study indicated that high concentrations of azelastine might actually inhibit parasympathetic function of the trachea. Azelastine might reduce asthma attacks in rhinitis patients because it could inhibit parasympathetic function and reduce methacholine-induced contraction of tracheal smooth muscle.

Original languageEnglish
Pages (from-to)211-215
Number of pages5
JournalRhinology
Volume48
Issue number2
DOIs
Publication statusPublished - Jun 2010
Externally publishedYes

Fingerprint

azelastine
Nasal Sprays
Smooth Muscle
Methacholine Chloride
Trachea
Rhinitis
Sneezing
Histamine Receptors
Muscle Tonus
Nasal Mucosa
Muscle Contraction
Nose
Inhalation
Electric Stimulation
Oral Administration
Anti-Inflammatory Agents
Asthma

Keywords

  • Azelastine
  • Histamine receptor-1 antagonist
  • In vitro study
  • Smooth muscle
  • Trachea

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Azelastine nasal spray inhibiting parasympathetic function of tracheal smooth muscle. / Wang, Hsing Won; Chou, Ying Liang; Chu, Yueng Hsiang.

In: Rhinology, Vol. 48, No. 2, 06.2010, p. 211-215.

Research output: Contribution to journalArticle

Wang, Hsing Won ; Chou, Ying Liang ; Chu, Yueng Hsiang. / Azelastine nasal spray inhibiting parasympathetic function of tracheal smooth muscle. In: Rhinology. 2010 ; Vol. 48, No. 2. pp. 211-215.
@article{1bd7a0980c6346ce8897891a680c3be9,
title = "Azelastine nasal spray inhibiting parasympathetic function of tracheal smooth muscle",
abstract = "Background: Azelastine hydrochloride is a histamine receptor-1 H 1 antagonist with antiinflammatory properties that is available in the United States as Astelin Nasal Spray for rhinitis patients who are suffering from sneezing and rhinorrhea. The effect of H1 antagonists on nasal mucosa in vivo is well known; however, the effect of the drug on tracheal smooth muscle has rarely been explored. During administration via oral intake or inhalation of the H1 antagonist for nasal symptoms, it might affect the trachea. Methods: We examined the effectiveness of azelastine on isolated rat tracheal smooth muscle by testing: 1) the effect on tracheal smooth muscle resting tension; 2) the effect on contraction caused by 106 M methacholine as a parasympathetic mimetic; and 3) the effect on electrically induced tracheal smooth muscle contractions. Results: The results indicated that addition of methacholine to the incubation medium caused the trachea to contract in a dose-dependent manner. Addition of azelastine at doses of 10 5 M or above elicited a significant relaxation response to 10 6 M methacholine-induced contraction. Azelastine could inhibit electrical field stimulation-induced spike contraction. It alone had a minimal effect on the basal tension of trachea as the concentration increased. Conclusions: This study indicated that high concentrations of azelastine might actually inhibit parasympathetic function of the trachea. Azelastine might reduce asthma attacks in rhinitis patients because it could inhibit parasympathetic function and reduce methacholine-induced contraction of tracheal smooth muscle.",
keywords = "Azelastine, Histamine receptor-1 antagonist, In vitro study, Smooth muscle, Trachea",
author = "Wang, {Hsing Won} and Chou, {Ying Liang} and Chu, {Yueng Hsiang}",
year = "2010",
month = "6",
doi = "10.4193/Rhin09.109",
language = "English",
volume = "48",
pages = "211--215",
journal = "Rhinology",
issn = "0300-0729",
publisher = "University Hospital Utrecht",
number = "2",

}

TY - JOUR

T1 - Azelastine nasal spray inhibiting parasympathetic function of tracheal smooth muscle

AU - Wang, Hsing Won

AU - Chou, Ying Liang

AU - Chu, Yueng Hsiang

PY - 2010/6

Y1 - 2010/6

N2 - Background: Azelastine hydrochloride is a histamine receptor-1 H 1 antagonist with antiinflammatory properties that is available in the United States as Astelin Nasal Spray for rhinitis patients who are suffering from sneezing and rhinorrhea. The effect of H1 antagonists on nasal mucosa in vivo is well known; however, the effect of the drug on tracheal smooth muscle has rarely been explored. During administration via oral intake or inhalation of the H1 antagonist for nasal symptoms, it might affect the trachea. Methods: We examined the effectiveness of azelastine on isolated rat tracheal smooth muscle by testing: 1) the effect on tracheal smooth muscle resting tension; 2) the effect on contraction caused by 106 M methacholine as a parasympathetic mimetic; and 3) the effect on electrically induced tracheal smooth muscle contractions. Results: The results indicated that addition of methacholine to the incubation medium caused the trachea to contract in a dose-dependent manner. Addition of azelastine at doses of 10 5 M or above elicited a significant relaxation response to 10 6 M methacholine-induced contraction. Azelastine could inhibit electrical field stimulation-induced spike contraction. It alone had a minimal effect on the basal tension of trachea as the concentration increased. Conclusions: This study indicated that high concentrations of azelastine might actually inhibit parasympathetic function of the trachea. Azelastine might reduce asthma attacks in rhinitis patients because it could inhibit parasympathetic function and reduce methacholine-induced contraction of tracheal smooth muscle.

AB - Background: Azelastine hydrochloride is a histamine receptor-1 H 1 antagonist with antiinflammatory properties that is available in the United States as Astelin Nasal Spray for rhinitis patients who are suffering from sneezing and rhinorrhea. The effect of H1 antagonists on nasal mucosa in vivo is well known; however, the effect of the drug on tracheal smooth muscle has rarely been explored. During administration via oral intake or inhalation of the H1 antagonist for nasal symptoms, it might affect the trachea. Methods: We examined the effectiveness of azelastine on isolated rat tracheal smooth muscle by testing: 1) the effect on tracheal smooth muscle resting tension; 2) the effect on contraction caused by 106 M methacholine as a parasympathetic mimetic; and 3) the effect on electrically induced tracheal smooth muscle contractions. Results: The results indicated that addition of methacholine to the incubation medium caused the trachea to contract in a dose-dependent manner. Addition of azelastine at doses of 10 5 M or above elicited a significant relaxation response to 10 6 M methacholine-induced contraction. Azelastine could inhibit electrical field stimulation-induced spike contraction. It alone had a minimal effect on the basal tension of trachea as the concentration increased. Conclusions: This study indicated that high concentrations of azelastine might actually inhibit parasympathetic function of the trachea. Azelastine might reduce asthma attacks in rhinitis patients because it could inhibit parasympathetic function and reduce methacholine-induced contraction of tracheal smooth muscle.

KW - Azelastine

KW - Histamine receptor-1 antagonist

KW - In vitro study

KW - Smooth muscle

KW - Trachea

UR - http://www.scopus.com/inward/record.url?scp=77952989777&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952989777&partnerID=8YFLogxK

U2 - 10.4193/Rhin09.109

DO - 10.4193/Rhin09.109

M3 - Article

VL - 48

SP - 211

EP - 215

JO - Rhinology

JF - Rhinology

SN - 0300-0729

IS - 2

ER -